Skip to main content

Keshan Disease

  • Chapter
  • First Online:
Endemic Disease in China

Part of the book series: Public Health in China ((PUBHECH,volume 2))

Abstract

Keshan disease (KD) is a novel cardiomyopathy of unclear cause which only occurred in some poor rural areas of China, characterized by obvious yearly and seasonal prevalence as well as vulnerability for self-sufficient farming population, killing hundreds of thousands of people over last century. Based on time course of onset and cardiac function of a suffering patient, KD is generally classified into four transformable types: acute type, sub-acute type, chronic type, and latent type. And their major clinical manifestations are cardiac dysfunction and arrhythmia.

KD was first recognized in medicine in the period when Japan invaded Northeast China. Since 1949, Chinese governments have made great efforts in fighting against KD epidemics, through broad social mobilization and engagement of local residents, especially deployment of substantial resources including money and medical teams to stem the outbreaks and save lives with combined measures. In the 1960s, Chinese investigators achieved multiple groundbreaking discoveries in the control and prevention of KD—several plausible etiological hypotheses and highly effective approaches for emergency rescue of critically ill patients by high-dose intravenous vitamin C therapy and for community-based primary prevention by selenium supplementation or balanced diet. Most importantly, since China’s open policy in 1978, the overall prevalence of KD has begun to decline dramatically thanks to rapid economic development in affected villages, reaching the lowest level ever and sustaining a steady state. Ultimately, we won the battle but at immense cost. Relevant sectors of governments have moved on, shifted from 1990 to focus on the disease surveillance and home care for heart failure, and believed that it would be completely eliminated following the implementation of poverty relief programs.

In this chapter, we provide basic knowledge on KD from perspectives of clinical medicine, pathology and epidemiology, and will particularly give emphasis on the major accomplishments and experiences worth spreading by reviewing its past control history.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Xu HC. A monument to the control of Keshan disease. In the Documentary of endemic disease prevention and treatment in Heilongjiang Province. Harbin: Helongjiang People’s Press; 1994.

    Google Scholar 

  2. Yu WH. Keshan disease and its control research in China. Beijing: China Environmental Science Press; 1987.

    Google Scholar 

  3. Sun DJ. Endemiology. Beijing: People’s Medical Publishing House; 2011.

    Google Scholar 

  4. Tan JA, An WY, Li RB. The geo-medical characteristics of Keshan disease. In: Keshan disease prevention and treatment in China: Chinese Environmental Sciences Press; 1987. p. 254–64.

    Google Scholar 

  5. Wang T, Hou J, Zhang LJ. National Keshan disease surveillance in 2007. Chin J Endemiol. 2008;27(4):412–5.

    Google Scholar 

  6. Sun SQ. Mysterious cause of Keshan disease: a medical puzzle for one hundred years. In: 10,000 Selected problems in science (medicine). Beijing: Science Press; 2011.

    Google Scholar 

  7. Xie JK. Engagement in the control and prevention of Keshan disease for 28 years along our own created path. Acta ademiae Medicinae Xi’an. 1984;5(4):476–81.

    Google Scholar 

  8. Xu GL. The effectiveness of sodium selenite on prevention of acute attacks of Keshan diseases. Chin Med J. 1979;92:471–6.

    Google Scholar 

  9. Yu WH. Keshan disease in China. Harbin: Heilongjiang Science and Technology Press; 2002.

    Google Scholar 

  10. Lin ZG. About the cause of Keshan disease. In: Symposium of national seminar on endemic disease control. Xi’an: Leadership Group Office of Shaanxi Provincial CPC Committee on Endemic Disease Control; 1962.

    Google Scholar 

  11. Zhou HH, Wang T. Progress in the etiological studies of Keshan disease. Chin J Endemiol. 2015;34(6):466–8.

    CAS  Google Scholar 

  12. Guo KD. Progress in the study of mycotoxin poisoning hypothesis on keshan disease in the past 30 years. Med Res Commun. 1986;15(10):289–94.

    Google Scholar 

  13. Yang JB, Yang QH. An etiological study on Keshan disease. Chin J Endemiol. 2000;19(5):350–5.

    Google Scholar 

  14. Xia DY. The diagnosis and treatment of acute Keshan disease. J Pract Med J. 1985;5(10):560–562, 535.

    Google Scholar 

  15. Clinical Group of Keshan Disease Research Laboratory, Jilin Medical University. Clinical manifestations of subacute Keshan disease. J Jilin Med Univ. 1976;8(3):19–28.

    Google Scholar 

  16. Xia DY. The procedure and method of diagnosis and differential diagnosis of Keshan disease. J Pract Intern Med. 1989;9(9):459–60.

    Google Scholar 

  17. The State Technology Supervision Bureau and the Ministry of Health of the People’s Republic of China. Criteria for diagnosis of Keshan disease (GB 17021-1997). National Standards of the People’s Republic of China. Standards Press of China; 1998. p. 1–3.

    Google Scholar 

  18. The Ministry of Health of the People’s Republic of China. Diagnosis of Keshan disease (WS/T 210-2011). Health Standards of the People’s Republic of China. Standards Press of China; 2011.

    Google Scholar 

  19. Gu BQ, Li CR, Shi DZ, Jia WZ, Guo SS. The study of cardiac pathological changes in Keshan diasease I. Basic pathological changes. J Harbin Med Univ. 1965;4(1):18–21, 31–4

    Google Scholar 

  20. Shi DZ, Gu BQ. The study of cardiac pathological changes in Keshan diasease III. The relationship between myocardial necrosis and coronary vessels. J Harbin Med Univ. 1965;4(1):28–30, 35

    Google Scholar 

  21. Gu BQ, Shi DZ, Jia WZ, Li CR, Guo SS. The study on cardiac pathological changes in Keshan diasease II. The type of cardiac pathological changes. J Harbin Med Univ. 1965;4(1):22–7, 31–4

    Google Scholar 

  22. Wang SC. Changing the way of thinking for establishing the therapy of high-dose vitamin C - in memory of the 60 anniversary of the discovery of Keshan disease and the 35 anniversary of the therapy of high-dose vitamin C founded. Bull Endem Dis. 1996;11(2):7–11.

    CAS  Google Scholar 

  23. Chen JS. Observations of the effect of sodium selenite in the prevention of Keshan diseases. Acta Nutrimenta Sin. 1982;4:243–9.

    Google Scholar 

  24. Wang T, Hou J, Li Q, Zhang LJ, Li XZ, Gao L, Pei JR, Deng J, et al. National Keshan disease surveillance in 2004. Chin J Endemiol. 2005;24(4):401–3.

    Google Scholar 

  25. Wang T, Hou J, Li Q. National Keshan disease surveillance in 2005. Chin J Endemiol. 2006;25(4):405–7.

    Google Scholar 

  26. Elliott P, Wartenberg D. Spatial epidemiology: current approaches and future challenges. Environ Health Perspect. 2004;112:998–1006.

    Article  Google Scholar 

  27. Rothman KJ. Modern epidemiology. Boston: Little Brown; 1986.

    Google Scholar 

  28. Rothman KJ. Epidemiology, an introduction. Oxford: Oxford University Press; 2002.

    Google Scholar 

  29. Elwood M. Critical appraisal of epidemiological studies and clinical trials. Oxford: Oxford University Press; 2003.

    Google Scholar 

  30. Savitz DA. Interpreting epidemiologic evidence: strategies for study design and analysis. Oxford: Oxford University Press; 2003.

    Book  Google Scholar 

  31. Ahrens W, Pigeot I, editors. Handbook of epidemiology. Berlin: Springer; 2005.

    Google Scholar 

  32. Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  33. Centers for Disease Control (CDC). CDC MMWR guidelines for evaluating surveillance systems. Morb Mortal Wkly Rep. 1988;37(Suppl 5):1–18. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001769.htm. Accessed 2 June 2012

    Google Scholar 

  34. Centers for Disease Control (CDC). Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep. 2001;50(RR-13):13–25.

    Google Scholar 

  35. The Ministry of Health of the Peoples Republic of China. Protocol of national KD surveillance. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/s5874/200908/42374.htm. Accessed 1 June 2012.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dianjun Sun .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sun, D., Sun, S., Feng, H., Hou, J. (2019). Keshan Disease. In: Sun, D. (eds) Endemic Disease in China. Public Health in China, vol 2. Springer, Singapore. https://doi.org/10.1007/978-981-13-2529-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2529-8_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2528-1

  • Online ISBN: 978-981-13-2529-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics